upgrade to Tier 1 to access blurred content, display up to 300 records, and unlimited CSV download
Data last updated 2024-04-28 04:05:40 -0500 US CDT
Insider Sentiment
| Company Name | Sector | Industry | Shares Outstanding(Mil) | 52-week High/Low | Period | Acq/Dsp Transaction Countb | Ids/Sec/Mkt Quantc | Acq/Dsp Shares Amountb | Acq/Dsp PctSOd |
|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb Co | Health Care | Pharmaceuticals | 2022.19 |
44.3
69.7
44.9
|
3-month |
0 / 0
|
|
0 / 0
|
0.0 / 0.0 |
| 6-month |
3 / 0
|
|
13571 / 0
|
0.0 / 0.0 |
Data last updated 2024-04-27 07:55:23 -0500 US CDT
Major Shareholders
| Shareholder | Relation | Report Date | Holding Pct | Sharesa | Shares(Previous Report Date)a | Transactions (3 month)b | Transactions (6 month)b |
|---|---|---|---|---|---|---|---|
| Andreotti Lamberto | Director | 2017-04-10 | 0.1% | 1176844 (-2.7%, NA%) | 1210844 (2017-04-04) | ||
| Leung Sandra | EVP, General Counsel | 2024-03-12 | 0.0% | 448106 (3.7%, 3.7%) | 432045 (2023-11-24) | ||
| Bancroft Charles A | EVP, Head of Integration | 2020-03-12 | 0.0% | 437534 (11.5%, NA%) | 392309 (2020-01-17) | ||
| Caforio Giovanni | Executive Chair of the Board | 2024-03-12 | 0.0% | 432266 (17.6%, 17.6%) | 367495 (2023-10-12) | ||
| Cuss Francis M | EVP & CSO | 2017-03-14 | 0.0% | 321905 (11.1%, NA%) | 289731 (2016-07-06) | ||
| Elkins David V | EVP, Chief Financial Officer | 2024-03-12 | 0.0% | 195183 (15.6%, 15.6%) | 168825 (2023-12-05) | ||
| Boerner Christopher S. | CEO | 2024-03-12 | 0.0% | 101205 (22.4%, 22.4%) | 82672 (2023-12-07) |
C: 2 / 0
S: 5071 / 0 P: 49.22 / NA |
|
| Daniels Brian | SVP Global Dev & Med Affairs | 2014-07-02 | 0.0% | 94374 (2.8%, NA%) | 91806 (2014-03-12) | ||
| Cornelius James M | Director | 2015-04-02 | 0.0% | 79851 (0.5%, NA%) | 79464 (2015-02-03) | ||
| Elicker John E | EVP, Investor Relations | 2020-03-12 | 0.0% | 70945 (20.9%, NA%) | 58665 (2020-03-06) | ||
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 2024-03-12 | 0.0% | 60279 (27.6%, 27.6%) | 47245 (2023-07-05) | ||
| Vessey Rupert | EVP & President, Research | 2023-05-04 | 0.0% | 48406 (-50.9%, NA%) | 98786 (2023-03-14) | ||
| Samuels Theodore R. Ii | Director | 2023-11-21 | 0.0% | 35500 (NA%, NA%) | 0 (2023-04-04) |
C: 1 / 0
S: 8500 / 0 P: 49.81 / NA |
|
| Powell Ann | EVP, Chief Human Resources | 2023-08-28 | 0.0% | 27868 (-39.1%, NA%) | 45854 (2023-03-14) | ||
| Lenkowsky Adam | EVP, Chief Commercial Officer | 2024-03-12 | 0.0% | 16200 (53.2%, 53.2%) | 10574 (2023-06-06) | ||
| Plenge Robert M | EVP, Chief Research Officer | 2024-03-12 | 0.0% | 13171 (84.8%, 84.8%) | 7126 (2023-12-05) |
a Total of direct and indirect accounts with percentage change comparing with (previous report, 3 months ago). The latter is NA when no change was found in the last 3 months.
Notice: Shares amount and percentage change 1) do not reflect intraday conversion and execution of derivative securities. 2) may subject to correction on amendment filing.
b Vital&Spontaneous transactions of the past 3 and 6 months, respectively. For acquisitions, code P (open market purchase), L (small acquisition), and I (at discretion of broker) are counted. For dispositions, code S (open market sell), D (sell back to issuer) and I (at discretion of broker) are counted. "C:" count of number of transactions. "S:" shares amount involved in corrresponding transactions. "P:" average per share price of the transactions (for reference only). Horizontal bar chart denotes shares amount of acquisitions and dispositions. Black thin bar is fixed size ruler for easy comparison between reporters.
c Quantile value of transaction count in b among industry peers, sector peers, and the market, respectively.
d Percentage of transaction shares amount to shares outstanding.
Notice: red exclamation mark (!) represents the reporter has Form 4 amendment filings in the latest three reports.
Non-derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Non-derivative Transactions Table
CSV download
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
|
Tips: type "code_p" to show transactions with code "P".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | 2024-04-01 | 2024-04-01 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | acq | 3306.0 | 50.61 | 0.02 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 6532.0 | 2022.19 (BMY) |
| 2024-04-02 | 2024-04-01 | 2024-04-01 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | dsp | 1196.0 | 18.31 | 0.01 | 52.99 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F | 5336.0 | 2022.19 (BMY) |
| 2024-04-02 | 2024-04-01 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | holding | 818.59 | 0 | 0.0 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Caforio Giovanni | EXECUTIVE CHAIR OF THE BOARD | acq | 190130.0 | 35.9 | 0.94 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 529662.333
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Caforio Giovanni | EXECUTIVE CHAIR OF THE BOARD | dsp | 125359.0 | 22.48 | 0.62 | 29.1 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 432266.333
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 4 | Hickey Benjamin | PRESIDENT, RAYZEBIO ORG. | holding | 780.0 | 0 | 0.0 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Hickey Benjamin | PRESIDENT, RAYZEBIO ORG. | holding | 91.0 | 0 | 0.0 | 0.0 | By Spouse | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | holding | 215.72 | 0 | 0.0 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | acq | 64326.0 | 28.58 | 0.32 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 225111.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | dsp | 37970.0 | 16.3 | 0.19 | 26.24 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 194968.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | holding | 4292.644 | 0 | 0.02 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | holding | 5257.876 | 0 | 0.03 | 0.0 | By Spouse | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | dsp | 8892.0 | 57.21 | 0.04 | 26.15 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 6650.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | acq | 15016.0 | 100 | 0.07 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 13859.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | acq | 54638.0 | 42.1 | 0.27 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 129769.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | dsp | 36105.0 | 26.29 | 0.18 | 28.91 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 101205.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 4351.0 | 100 | 0.02 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 3781.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 2625.0 | 60.33 | 0.01 | 26.8 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 1726.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 4 | Meyers Gregory Scott | EVP, CHIEF DIGITAL & TECH OFF. | holding | 5286.0 | 0 | 0.03 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Plenge Robert M | EVP, CHIEF RESEARCH OFFICER | dsp | 4754.0 | 29.58 | 0.02 | 22.23 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 11315.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Plenge Robert M | EVP, CHIEF RESEARCH OFFICER | acq | 9143.0 | 60.22 | 0.05 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 15182.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 4 | Plenge Robert M | EVP, CHIEF RESEARCH OFFICER | holding | 200.0 | 0 | 0.0 | 0.0 | Family Trust | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Plenge Robert M | EVP, CHIEF RESEARCH OFFICER | holding | 1656.842 | 0 | 0.01 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | holding | 3226.0 | 0 | 0.02 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | holding | 818.59 | 0 | 0.0 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) | ||
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Holzer Phil M | SVP AND CONTROLLER | acq | 5520.0 | 37.01 | 0.03 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 14916.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Holzer Phil M | SVP AND CONTROLLER | dsp | 3071.0 | 19.77 | 0.02 | 24.33 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 12460.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Leung Sandra | EVP, GENERAL COUNSEL | dsp | 30813.0 | 8.15 | 0.15 | 29.08 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 347385.333
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Leung Sandra | EVP, GENERAL COUNSEL | acq | 46784.0 | 12.6 | 0.23 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 371312.333
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 4 | Leung Sandra | EVP, GENERAL COUNSEL | holding | 7285.12 | 0 | 0.04 | 0.0 | Bms Savings And Investment Program | Common Stock | BRISTOL MYERS SQUIBB CO | NA | 2022.19 (BMY) |
Derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Derivative Transactions Table
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Bhatt Deepak | DIRECTOR | acq | 161.35 | 1.61 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 10050.37 | 2022.19 (BMY) |
| 2024-04-02 | 2024-04-01 | 2024-04-01 | 4 | Shanahan Karin | EVP, GLOB. PROD. DEV. & SUPPLY | dsp | 3306.0 | 33.33 | 0.02 | 0.0 | Direct | Restricted Stock Units | BRISTOL MYERS SQUIBB CO | code M | 6613.0 | 2022.19 (BMY) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Yale Phyllis R | DIRECTOR | acq | 645.399 | 2.34 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 27595.249 | 2022.19 (BMY) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Samuels Theodore R. Ii | DIRECTOR | acq | 921.999 | 1.93 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 47858.919 | 2022.19 (BMY) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Arduini Peter J | DIRECTOR | acq | 645.399 | 1.22 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 52708.649 | 2022.19 (BMY) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Rice Derica W | DIRECTOR | acq | 691.499 | 2.93 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 23634.109 | 2022.19 (BMY) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Storch Gerald L | DIRECTOR | acq | 691.499 | 0.78 | 0.0 | 54.23 | Direct | Deferred Share Units | BRISTOL MYERS SQUIBB CO | code A | 88158.649 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Caforio Giovanni | EXECUTIVE CHAIR OF THE BOARD | dsp | 142904.0 | 100.0 | 0.71 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Caforio Giovanni | EXECUTIVE CHAIR OF THE BOARD | dsp | 92859.0 | 56.93 | 0.46 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 70258.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hickey Benjamin | PRESIDENT, RAYZEBIO ORG. | acq | 3870.0 | 100.0 | 0.02 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 3870.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hickey Benjamin | PRESIDENT, RAYZEBIO ORG. | acq | 5805.0 | 100.0 | 0.03 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 5805.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | acq | 41796.0 | 100.0 | 0.21 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 41796.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | dsp | 31625.0 | 57.15 | 0.16 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 23712.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | acq | 62693.0 | 100.0 | 0.31 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 62693.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Elkins David V | EVP, CHIEF FINANCIAL OFFICER | dsp | 48257.0 | 100.0 | 0.24 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | dsp | 7425.0 | 55.3 | 0.04 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 6001.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | acq | 20898.0 | 100.0 | 0.1 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 20898.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | dsp | 11416.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Lenkowsky Adam | EVP, CHIEF COMMERCIAL OFFICER | acq | 31347.0 | 100.0 | 0.16 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 31347.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | dsp | 41910.0 | 100.0 | 0.21 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | acq | 148026.0 | 100.0 | 0.73 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 148026.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | dsp | 26077.0 | 56.35 | 0.13 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 20199.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Boerner Christopher S. | CEO | acq | 98684.0 | 100.0 | 0.49 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 98684.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 3268.0 | 100.0 | 0.02 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 7546.0 | 100.0 | 0.04 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 7546.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 5031.0 | 100.0 | 0.02 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 5031.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 2968.0 | 48.5 | 0.01 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 3152.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Meyers Gregory Scott | EVP, CHIEF DIGITAL & TECH OFF. | dsp | 6129.0 | 38.28 | 0.03 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J | 9880.0
|
2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Meyers Gregory Scott | EVP, CHIEF DIGITAL & TECH OFF. | acq | 19350.0 | 100.0 | 0.1 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 19350.0 | 2022.19 (BMY) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Meyers Gregory Scott | EVP, CHIEF DIGITAL & TECH OFF. | acq | 29025.0 | 100.0 | 0.14 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 29025.0 | 2022.19 (BMY) |
Form 3 CSV download
| Filing Date | Date requiring statement | Form Type | Reporter | Relation | Amounta | ‱(SO)c | Avg Excercisable Prcd | Account | Type | Full Name | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-02-26 | 3 | HICKEY BENJAMIN | President, RayzeBio Org. | 91.0 | 0.0 | 0.0 | by spouse | common stock | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-03-04 | 2024-02-26 | 3 | HICKEY BENJAMIN | President, RayzeBio Org. | 780.0 | 0.0 | 0.0 | Direct | common stock | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-03-04 | 2024-02-26 | 3 | HICKEY BENJAMIN | President, RayzeBio Org. | 30236.0 | 0.15 | 0.0 | Direct | restricted stock units | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-02-23 | 2024-02-15 | 3 | HOLZER PHIL M | SVP and Controller | 10011.0 | 0.05 | 0.0 | Direct | common stock | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-02-23 | 2024-02-15 | 3 | HOLZER PHIL M | SVP and Controller | 13679.0
|
0.07 | 0.0 | Direct | performance shares | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-02-23 | 2024-02-15 | 3 | HOLZER PHIL M | SVP and Controller | 7521.0
|
0.04 | 0.0 | Direct | market share units | BRISTOL MYERS SQUIBB CO | 2022.19 (BMY~) R |
| 2024-01-03 | 2024-01-01 | 3 | POOLE AHN AMANDA | EVP, Chief Human Resources | 164.325 | 0.0 | 0.0 | bms savings and investment program | common stock | BRISTOL MYERS SQUIBB CO | 2034.76 (BMY~) R |
| 2024-01-03 | 2024-01-01 | 3 | POOLE AHN AMANDA | EVP, Chief Human Resources | 13823.0
|
0.07 | 0.0 | Direct | performance shares | BRISTOL MYERS SQUIBB CO | 2034.76 (BMY~) R |
| 2024-01-03 | 2024-01-01 | 3 | POOLE AHN AMANDA | EVP, Chief Human Resources | 7653.0
|
0.04 | 0.0 | Direct | market share units | BRISTOL MYERS SQUIBB CO | 2034.76 (BMY~) R |
| 2023-12-20 | 2023-12-15 | 3 | HOCH LYNELLE | President, Cell Therapy Org. | 14587.0
|
0.07 | 0.0 | Direct | performance shares | BRISTOL MYERS SQUIBB CO | 2034.76 (BMY~) R |
| 2023-12-20 | 2023-12-15 | 3 | HOCH LYNELLE | President, Cell Therapy Org. | 8339.0
|
0.04 | 0.0 | Direct | market share units | BRISTOL MYERS SQUIBB CO | 2034.76 (BMY~) R |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to 30 records per table for current tier. (Access Guide)